24 results on '"Lasnon, Charline"'
Search Results
2. New PET technologies – embracing progress and pushing the limits
3. A PSMA-targeted theranostic approach is unlikely to be efficient in serous ovarian cancers
4. More fat, less migration: breast density as a predictor of sentinel lymph node non-visualization in breast cancer
5. Baseline 18F-FDG PET radiomic features as predictors of 2-year event-free survival in diffuse large B cell lymphomas treated with immunochemotherapy
6. Can someone look after my children while I write this COVID-19 paper?
7. Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer
8. HYPHYCA: a prospective study in 613 patients conducting a comprehensive analysis for predictive factors of physiological 18F-FDG anal uptake
9. Assessment of alteration in liver 18F–FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score
10. Reply to: “All that glitters is not gold – new reconstruction methods using Deauville criteria for patient reporting”
11. Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma
12. Impact of the EARL harmonization program on automatic delineation of metabolic active tumour volumes (MATVs)
13. Comprehensive analysis of the influence of G-CSF on the biodistribution of 18F-FDG in lymphoma patients: insights for PET/CT scheduling
14. Implications of reconstruction protocol for histo-biological characterisation of breast cancers using FDG-PET radiomics
15. Combining baseline TMTV and gene profiling for a better risk stratification in diffuse large B cell lymphoma
16. EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies
17. 18F-FDG PET/CT heterogeneity quantification through textural features in the era of harmonisation programs: a focus on lung cancer
18. Correction to: Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer
19. Reply to the Letter to the Editor from Peters et al: On the use of the liver as a reference organ for Deauville scoring in lymphoma patients and how it may be affected by liver steatosis
20. Quantifying and correcting for tail vein extravasation in small animal PET scans in cancer research: is there an impact on therapy assessment?
21. Patient’s weight: a neglected cause of variability in SUV measurements? A survey from an EARL accredited PET centre in 513 patients
22. Contrast-enhanced small-animal PET/CT in cancer research: strong improvement of diagnostic accuracy without significant alteration of quantitative accuracy and NEMA NU 4–2008 image quality parameters
23. Correction to: Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma
24. Diuretic 18 F-FDG PET/CT for therapy monitoring in urothelial bladder cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.